Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Osteoporosis
How do you manage hepatotoxicity thought to be related to Romosozumab use?
Have you seen liver toxicity associated with Romosozumab?
Related Questions
Is elevated bone specific alkaline phosphatase an absolute contraindication to teriparatide?
Is it safe to combine Prolia with other immunosuppressants?
Are there any concerns with using denosumab in a patient with chronic hepatitis B infection on antiviral therapy?
What treatment options would you consider for a young patient with limited mobility, low bone mass and multiple vertebral compression fractures who is on dialysis for advanced kidney disease?
Is there a maximum duration for raloxifene use?
How should we interpret DXA scans in patients with Ankylosing Spondylitis who have ankylosis of the spine?
Can lupus anticoagulant be positive despite a normal aPTT?
Would you order a repeat DEXA scan 1 year later for a kidney transplant patient who had an initial DEXA scan within the first 6 months post-transplant showing osteopenia but no history of fractures, and who has been stable on glucocorticoid-free immunosuppressive therapy?
How do you approach management of bone marrow involvement in sarcoidosis?
How do you approach a patient with sarcoidosis who cannot tolerate steroids and who is developing ILD?
